Last €0.23 EUR
Change Today +0.019 / 9.09%
Volume 310.2K
HYGEIA On Other Exchanges
Symbol
Exchange
Frankfurt
As of 10:16 AM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

diagnostic & therapeutic (HYGEIA) Snapshot

Open
€0.21
Previous Close
€0.21
Day High
€0.23
Day Low
€0.21
52 Week High
03/13/14 - €0.51
52 Week Low
11/10/14 - €0.17
Market Cap
69.7M
Average Volume 10 Days
285.0K
EPS TTM
€-0.11
Shares Outstanding
305.7M
EX-Date
07/8/14
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for DIAGNOSTIC & THERAPEUTIC (HYGEIA)

Related News

No related news articles were found.

diagnostic & therapeutic (HYGEIA) Related Businessweek News

No Related Businessweek News Found

diagnostic & therapeutic (HYGEIA) Details

Diagnostic and Therapeutic Center of Athens Hygeia SA provides primary and secondary healthcare services in Greece and internationally. The company offers diagnostic and medical treatment services. It operates gamma-KNIFE brain radio surgery, positron emission tomography, radiation oncology, organ transplant, one-day surgery, interventional neuroradiology and cerebral aneurysm embolization, neurosurgical system, and one day treatment centers, as well as Da Vinci S, a robotic surgery system. As of December 31, 2013, the company owned 4 private hospitals in Greece and Albania with a total capacity of 1,261 licensed beds, 58 operating rooms, 34 delivery rooms, and 9 intensive care units. It is also involved in the import, trading, and supply of medical technology products; trading of pharmaceuticals and general medical supplies; operation of canteens and restaurants; and research, production, and trading of cosmetics, as well as offers supply, storage, marketing, and management services for the medical supplies, implants, and fixed equipment. The company was founded in 1970 and is based in Athens, Greece.

3,081 Employees
Last Reported Date: 03/31/14
Founded in 1970

diagnostic & therapeutic (HYGEIA) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

diagnostic & therapeutic (HYGEIA) Key Developments

Diagnostic & Therapeutic Center of Athens Hygeia S.A. Announces Group and Parent Financial Results for the Six Months of 2014

Diagnostic & Therapeutic Center of Athens Hygeia S.A. announced group and parent financial results for the six months of 2014. For the period, the company reported on group basis revenue of €115.07 million against €120.69 million a year ago. Adjusted revenue of €121.56 million against €120.69 million a year ago. EBITDA was €10.27 million against €15.71 million a year ago. Adjusted EBITDA was €16.76 million against €15.71 million a year ago. Net losses before taxes was €5.18 million against net income before tax of €0.93 million a year ago. Adjusted net income before taxes was €1.30 million against net income before tax of €0.93 million a year ago. Net losses was €5.60 million against €3.27 million a year ago. Adjusted losses was €0.06 million against €3.27 million a year ago. For the period, the company reported on parent basis revenue of €68.97 million against €72.64 million a year ago. Adjusted revenue of €72.58 million against €72.64 million a year ago. EBITDA was €9.98 million against €13.29 million a year ago. Adjusted EBITDA was €13.6 million against €13.29 million a year ago. Net earnings before taxes was €2.48 million against net income before tax of €1.37 million a year ago. Adjusted net income before taxes was €6.09 million against net income before tax of €1.37 million a year ago. Net earnings was €1.40 million against net loss of €3.10 million a year ago. Adjusted earnings was €4.08 million against adjusted loss of €3.10 million a year ago.

Diagnostic & Therapeutic Center of Athens Hygeia S.A., Annual General Meeting, May 27, 2014

Diagnostic & Therapeutic Center of Athens Hygeia S.A., Annual General Meeting, May 27, 2014., at 17:00 E. Europe Standard Time. Location: Nikolaos Louros Conference Centre, first level (ground floor) of MITERA Hospital. Agenda: To consider the submission and approval of the individual and consolidated financial statements for the 2013 fiscal year, and the relevant reports of the board of directors and the chartered accountants/auditors; to consider the discharge of board of directors members and chartered accountants/auditors from any liability with regard to the 2013 fiscal year activities; to consider the appointment of chartered accountants/auditors for the 2014 fiscal year; to consider the approval of remunerations and contracts in accordance with Articles 23 a and 24 of Codified Law 2190/1920; to consider the election of new board of directors; to consider the election of audit committee members in accordance with Article 37 of Law 3693/2008; to consider the modification of article 23 (general meeting notice/agenda) and 35 (fiscal year duration/annual financial statements) of the company's articles of incorporation; and to consider the other issues/announcements.

Diagnostic & Therapeutic Center of Athens Hygeia S.A., Board Meeting, Apr 14, 2014

Diagnostic & Therapeutic Center of Athens Hygeia S.A., Board Meeting, Apr 14, 2014. Agenda: To consider the Annual General Meeting.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HYGEIA:GA €0.23 EUR +0.019

HYGEIA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HYGEIA.
View Industry Companies
 

Industry Analysis

HYGEIA

Industry Average

Valuation HYGEIA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.3x
Price/Book 0.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DIAGNOSTIC & THERAPEUTIC, please visit www.hygeia.gr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.